Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,850.00    155.00 (2.32%)
Bid:
6,850.00
Ask:
6,855.00
Spread: 5.00 (0.073%)
Market Cap: £5.06b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

7 Nov 2008 07:00

RNS Number : 6666H
Spirax-Sarco Engineering PLC
07 November 2008
 



Spirax-Sarco Engineering plc

Charlton House

Cheltenham

Glos. GL53 8ER

News Release

Telephone: 01242 521361

Fax: 01242 581470

www.SpiraxSarcoEngineering.com

Friday 7th November 2008 [embargoed until 7.00 am]

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement based on the four month period to 31st October 2008.

Trading

As expected, we have begun to see some moderation in the pace of growth in demand from our customers, particularly in Continental Europe, although the overall organic sales growth trend in the first half year has broadly continued through October. Despite the Korean Won weakening sharply, currency effects have continued to move in our favour and have added 8% to Group revenues this year, with a larger benefit to operating profit.

Our business is today even more well spread across all geographic regions and across an even wider range of industries and products. We have a large element of replacement sales and the relatively high cost of energy has supported our energy-saving solutions for customers. These factors have historically provided some resilience.

Financial position

We continue to operate with a strong balance sheet. The Group had a net cash balance at 30th June 2008 of £12m, despite having made an initial £11m payment in February for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period, with net cash balances increasing to £26m at 31st October 2008. The company intends to purchase one million of its own shares to be held in Treasury to meet the requirements of the Group share schemes. The net liability in respect of post-retirement benefits rose to £33m (net of deferred tax) at the half-year and fluctuates in relation to movements in equity and bond markets, which remain volatile. We still expect capital expenditure to be higher than normal this year and in 2009.

Outlook

In our prospects statement in the half-year results announcement made in August, we noted the deteriorating global macro-economic environment, which has been confirmed by more recent GDP and Industrial Production rates and forecasts, and which increases the uncertainty looking forward. However, our business is well spread and generally resilient, and we have a strong balance sheet. We continue to invest for the long term, particularly in developing market areas where economic conditions look more favourable, and are focused on progressively growing our market share. Given continued beneficial exchange rates and no significant deterioration in trading conditions in our markets, we expect to achieve good progress for the year.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535236

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBDGGGGIL
Date   Source Headline
8th Jun 20261:24 pmRNSDirector/PDMR Shareholding
1st Jun 202610:28 amRNSChange in Major Shareholding
29th May 20262:24 pmRNSUpdate on Directorships held by Company Directors
27th May 20263:30 pmRNSDirector/PDMR Shareholding
26th May 20265:24 pmRNSDirector/PDMR Shareholding
19th May 20269:16 amRNSChange in Major Shareholding
14th May 20262:47 pmRNSExternal Directorships held by Company Directors
14th May 202610:39 amRNSDirector/PDMR Shareholding
13th May 20264:12 pmRNSResult of AGM
13th May 20267:00 amRNSTrading Update
8th May 20263:42 pmRNSChange in Major Shareholding
7th May 20269:03 amRNSDirector/PDMR Shareholding
8th Apr 20262:22 pmRNSDirector/PDMR Shareholding
8th Apr 20269:30 amRNSAnnual Report and Accounts 2025 and Notice of AGM
18th Mar 20264:53 pmRNSDirector/PDMR Shareholding
11th Mar 20261:53 pmRNSTotal Voting Rights
10th Mar 20265:01 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS2025 Full Year Results
10th Mar 20267:00 amRNS2025 Full Year Results
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
9th Mar 20263:35 pmRNSDirector/PDMR Shareholding
10th Feb 20269:30 amRNSChange in Director Details
6th Feb 20263:47 pmRNSDirector/PDMR Shareholding
2nd Feb 20261:50 pmRNSChange in Director Details
30th Jan 20262:19 pmRNSHolding(s) in Company
6th Jan 20263:10 pmRNSDirector/PDMR Shareholding
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 20252:12 pmRNSCorrection: Block Listing Application
18th Dec 202510:34 amRNSBlocklisting Application
9th Dec 20252:35 pmRNSDirector/PDMR Shareholding
18th Nov 20259:40 amRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTrading Update
7th Nov 20251:56 pmRNSDirector/PDMR Shareholding
5th Nov 20258:39 amRNSHolding(s) in Company
22nd Oct 20257:00 amRNSBoard Appointment
7th Oct 20255:08 pmRNSDirector/PDMR Shareholding
9th Sep 20257:00 amRNSDirector/PDMR Shareholding
1st Sep 20259:35 amRNSHolding(s) in Company
12th Aug 20257:00 amRNSBoard Committee Membership Update
12th Aug 20257:00 amRNS2025 Half Year Results
7th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20254:58 pmRNSDirector/PDMR Shareholding
9th Jul 20254:26 pmRNSDirector/PDMR Shareholding
13th Jun 20253:36 pmRNSDirector/PDMR Shareholding
14th May 20254:48 pmRNSResult of AGM
14th May 20257:00 amRNSTrading Update
8th May 202511:03 amRNSDirector/PDMR Shareholding
23rd Apr 20255:13 pmRNSChange in Director Details
22nd Apr 20253:52 pmRNSDirector/PDMR Shareholding
11th Apr 20255:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.